RESEARCH ALLIANCE CORPORATION III ANNOUNCES PRICING OF $75 MILLION INITIAL PUBLIC OFFERING
Rhea-AI Summary
Research Alliance Corporation III (Nasdaq:RACC) priced its initial public offering of 7,500,000 Class A ordinary shares at $10.00 per share, for gross proceeds of $75 million. The shares begin trading on the Nasdaq Capital Market on May 20, 2026, with closing expected May 21, 2026.
The SPAC, sponsored by an affiliate of RA Capital Management, aims to pursue a business combination, primarily in healthcare or healthcare-related industries. Leerink Partners is sole bookrunning manager, with participation from multiple institutional investors. The SEC declared the registration statement effective on May 19, 2026.
Positive
- IPO priced at $10 per share, raising $75 million gross proceeds
- Listing on Nasdaq Capital Market under ticker symbol RACC
- Sponsorship by an affiliate of RA Capital Management
- Focus on healthcare and healthcare-related targets for business combination
- Sole bookrunning managed by Leerink Partners with multiple institutional investors participating
- SEC effectiveness of registration statement obtained on May 19, 2026
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The Company, sponsored by an affiliate of RA Capital Management, L.P., is led by CEO Matthew Hammond, PhD, MBA and CBO/COO Henry Stusnick. The Company is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company may pursue an initial business combination in any business, industry, sector or geographical location, but the Company intends to focus its search on a target business in the healthcare or healthcare-related industries, where it believes the expertise of its management team will provide it with a competitive advantage in completing a successful initial business combination.
Leerink Partners is serving as the sole bookrunning manager for the offering.
The financing included participation from ADAR1 Capital, Affinity Asset Advisors, LLC, Balyasny Asset Management L.P., Braidwell LP, BVF Partners, Cormorant Asset Management, Foresite Capital, Janus Henderson Investors, Perceptive Advisors, SilverArc Capital, Spruce Street Capital, TCGX, Trails Edge Capital Partners, Venrock Healthcare Capital Partners, and other institutional investors.
The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from: Leerink Partners LLC, Attn: Syndicate Department, 53 State Street, 40th Floor,
A registration statement relating to the securities was declared effective by the
FORWARD-LOOKING STATEMENTS
This press release contains statements that constitute "forward-looking statements," including with respect to the proposed initial public offering and the anticipated use of the net proceeds from the offering. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the Company will ultimately complete a business combination transaction. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and preliminary prospectus for the Company's offering filed with the SEC. Copies of these documents are available on the SEC's website, at www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
View original content:https://www.prnewswire.com/news-releases/research-alliance-corporation-iii-announces-pricing-of-75-million-initial-public-offering-302777708.html
SOURCE Research Alliance Corporation III